Sinopharm Covid-19 booster weaker against Omicron - study
A Covid-19 booster shot produced by China's Sinopharm had "significantly lower" neutralising activity against the Omicron variant, Chinese researchers said in a paper, although they added the vaccine's efficacy against Omicron remained unclear.
The study - conducted by researchers from Shanghai Jiao Tong University and a Shanghai-based lab specialising in respiratory infectious diseases - compared the activity of Sinopharm's booster vaccine against an older coronavirus strain from Wuhan.
The neutralising antibody activity...
Verifying user
RM12.50 / month
- Unlimited access to award-winning journalism
- Comment and share your opinions on all our articles
- Gift interesting stories to your friends
- Tax deductable